NCT00314158 - A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension | Biotech Hunter

Enrollment

523

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions

Open-angle GlaucomaOcular Hypertension

Interventions

DRUG

Brinzolamide 10 mg/ml + Timolol 5 mg/ml eye drops, suspension

One drop twice daily in each study eye for six months

DRUG

Brinzolamide 10 mg/ml (AZOPT) eye drops, suspension

One drop twice daily in each study eye for six months

DRUG

Timolol 5 mg/ml eye drops, solution

One drop twice daily in each study eye for six months

Trial Locations (1)

United States Investigative Sites, Fort Worth